comparemela.com

Latest Breaking News On - Josh bartch - Page 3 : comparemela.com

Mydecine Innovations Group Announces Expected U K Dual

VANCOUVER, British Columbia, Sept. 27, 2023 (GLOBE NEWSWIRE) Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF).

United statesBritish columbiaUnited kingdomJoshua bartchJosh bartchUniversity of albertaAquis stock exchangeHealth canadaJohns hopkins universityMydecine innovations group incMydecine innovations groupInnovations groupAccess segmentAquis stockNorth americaJohns hopkins

Mydecine Innovations Group Closes Sale of Its Wholly-Owned

DENVER, Dec. 12, 2022 (GLOBE NEWSWIRE) Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology.

United statesUnited kingdomPangenomic naraJosh bartchMaryam marissenJoshua bartchMydecine innovations group incCanadian stock exchangeMindleap health incMydecine innovations groupPangenomic health incInnovations groupMindleap healthPangenomic healthEach unitCommon share

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomPangenomic naraJosh bartchMaryam marissenJoshua bartchMydecine innovations group incCanadian stock exchangeMindleap health incMydecine innovations groupPangenomic health incInnovations groupMindleap healthPangenomic healthEach unitCommon share

Mydecine Innovations Group Announces Common Share Subscription Agreement

29.08.2022 - DENVER, Aug. 29, 2022 (GLOBE NEWSWIRE) - Mydecine Innovations Group Inc. ( Mydecine or the Company ) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to . Seite 1

United statesJosh bartchMydecine innovations group incCompany the commonCompany the investorShelf prospectusCompany the draw amountInnovations groupCommon shareSubscription agreementDraw closingCommon sharesDraw notice

U S FDA Clears MYCO-001 for Multi-Site Government Funded

DENVER, June 17, 2022 (GLOBE NEWSWIRE) Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology.

United statesMorgan kervitskyJessica rigglemanJosh bartchMichaelp bogenschutzPeter hendricksJoshua bartchMatthew johnsonMydecine innovations group incRegulatory affairsNational institutes of healthDrug administrationDepartment of psychiatryDepartment of health behaviorBehavioral sciences at johns hopkins universityMydecine innovations group

vimarsana © 2020. All Rights Reserved.